Skip to main content
. 2002 Dec;236(6):794–805. doi: 10.1097/00000658-200212000-00012

graphic file with name 12FF9.jpg

Figure 9. Cumulative rate of at least one rejection in all African-American kidney transplant recipients in the mycophenolate mofetil era. Comparison of tacrolimus (FK)- and cyclosporin (CSA)-based immunosuppression. At 1 year the rate in African-American patients was 36% with cyclosporine-based therapy but only 9% with tacrolimus-based therapy (P < .0001).